Trials / Completed
CompletedNCT00602433
Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib
Evaluation of Hormonal Changes in Women on Erlotinib Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- Northwestern University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Studying samples of blood in the laboratory from patients receiving erlotinib may help doctors learn more about the effects of erlotinib on hormone levels. This clinical trial is looking at hormone changes in women with stage IIIB or stage IV non-small cell lung cancer receiving erlotinib.
Detailed description
Patients undergo a dermatology evaluation and complete the Polycystic Ovarian Syndrome (PCOS) research study questionnaire once. Blood samples are collected after an overnight fast. Samples are analyzed for circulating levels of total and bioavailable testosterone, dehydroepiandrosterone sulfate, and sex hormone binding globulin. Serum luteinizing hormone, follicle stimulating hormone, fasting glucose, and insulin levels are also assessed.
Conditions
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2009-08-01
- Completion
- 2009-08-01
- First posted
- 2008-01-28
- Last updated
- 2011-04-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00602433. Inclusion in this directory is not an endorsement.